EDGAR Filing Documents for 0001199073-17-000220

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001199073-17-000220

Filing Date

2017-03-30

Accepted

2017-03-30 08:05:29

Documents

Period of Report

2017-03-30

Document Format Files

Seq	Description	Document	Type	Size
1	ACASTI PHARMA INC. 6-K	acasti6k.htm	6-K	17730
2	EXHIBIT 99.1	exh99_1.htm	EX-99.1	19457
3		image00001.jpg	GRAPHIC	5346
	Complete submission text file	0001199073-17-000220.txt		45668

Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3

Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)